Updated January 17th, 2022 at 22:24 IST
Centre releases revised clinical guidance for management of adult COVID-19 patients
The National Task Force for COVID-19 under the Ministry of Health and Family Welfare issued revised clinical guidance for the management of COVID patients.
Advertisement
Amid the rising COVID-19 cases across the country, the Centre has revised guidelines for adult patients. The National Task Force for COVID-19 under the Ministry of Health and Family Welfare, on Monday, issued revised clinical guidance for the management of adult patients who are diagnosed with coronavirus.
COVID-19 National Task Force under Ministry of Health and Family Welfare releases revised clinical guidance for the management of adult COVID-19 patients pic.twitter.com/x4R6ZntVnz
— ANI (@ANI)
Centre's Revised Clinical Guidance
According to the revised guidelines, there are three categories of the disease - Mild, Moderate, and Severe - and patients will be treated as per the symptoms mentioned.
MILD Symptoms- COVID-19 patients with mild symptoms will experience fever without shortness of breath or hypoxia and upper respiratory tract.
Precaution: Home isolation and care
Must-Dos During Mild Symptoms
- Physical Distancing, indoor mask use, and strict hand hygiene need to be maintained.
- Symptomatic management (hydration, anti-pyretic, anti-tussive)
- Stay in contact with the treating physician
- Temperature and oxygen saturation need to be monitored constantly (by applying a SpO2 probe to fingers)
- Seek immediate medical attention if there is difficulty in breathing (SpO2 less than 93%)
MODERATE Symptoms- The COVID-19 patients with moderate symptoms will experience breathlessness and the SpO2 in the room temperature will be between 90 to 93%
Precaution: Admit in Hospital ward
Must-Dos During Moderate Symptoms
- The patient will be put on Oxygen support
- Preferred devices for oxygenation: non-rebreathing face mask
- Awake Proning should be encouraged in all patients
- Anti-inflammatory or immunomodulatory therapy will be needed
- Anticoagulation treatment with anticoagulant drugs in order to reduce the risk of the formation of blood clots
- Constant clinical monitoring will be required for breathing rate, hemodynamic instability, change in oxygen requirement
SEVERE Symptoms- The COVID-19 patient with Severe symptoms will experience major breathlessness and the SpO2 in the room temperature will be less than 90%
Precaution: Admit in HDU/ICU
Must-Dos During Severe Symptoms
- The patient will be put on Respiratory support
- Use of NIV in patients with increasing oxygen requirements
- Intubation should be prioritised if the patient not responding to NIV
- Use of institutional ventilatory management when required
- Anti-inflammatory or immunomodulatory therapy will be needed
- Anticoagulation treatment
- Constant clinical monitoring will be required for breathing rate, Hemodynamic Instability, change in oxygen requirement.
India's COVID-19 situation
Witnessing a marginal dip, India registered 2,58,089 new COVID-19 cases in the past 24 hours. After this, the country's total number of COVID-19 infections has risen to 3,73,80,253, with 16,56,341 active cases. Active cases make for 4.43% of all infections. So far, 8,209 total Omicron cases have been discovered, which is up 6.02% from yesterday. The positivity rate was recorded at 19.65%.
As much as 1,51,740 people recuperated from COVID, bringing the overall number of recoveries to 3,52,37,461. As a result, the recovery rate now stands at 94.27%. Around 385 people lost their lives to COVID, bringing the total death toll to 4,86,451, according to the health ministry. On Sunday, India had reported 2,71,202 new COVID-19 cases, with a positive rate of 16.28%.
(Image: PTI/Unsplash)
Advertisement
Published January 17th, 2022 at 22:24 IST